Search Results

• The A/C Enzymatic Homocysteine Assay is intended for the quantitative determination of total homocysteine (tHCY) in human plasma or serum.
• The device can assist in the diagnosis and treatment of patients suspected of having hyperhomocysteinemia.
• The A/C Enzymatic Homocysteine Assay Kit is only for in vitro diagnostic use.

The A/C Enzymatic Homocysteine Assay is calibrated with A/C Enzymatic Homocysteine Assay Calibrators. The A/C Enzymatic Homocysteine Assay is assayed for the verification of the accuracy and precision on the Hitachi 912 Automatic Analyzer.

The A/C Enzymatic Homocysteine Assay measures tHCY. The principle of the assay is that recombinant homocysteinase (rHCYase) produces hydrogen sulfide (H2S) from tHCY, which is quantified by use of N,N-dibutyl phenylene diamine (DBPDA), the combination of which forms a chromophore.

The A/C Enzymatic Homocysteine Assay on the Hitachi 912 Automatic Analyzer used four reagents, a number compatible with implementation on the Hitachi 912 Automatic Analyzer. We used 30 uL of EDTA plasma in a dithiothreitol (DTT) reduction reaction (1 mmol/L DTT, 0.2% Triton X-100 in 40 mmol/L sodium phosphate buffer [pH 8.3]) for 1.5 minutes to release bound homocysteine. The rHCYase reaction (0.05 mg/ml in 40 mmol/L sodium phosphate buffer [pH 8.3] with 20 umol/L pyridoxal 5-phosphate [PLP]) is then run for 3.5 minutes. The DBPDA chromophore (12.5 mmol/L DBPDA in 1.5 N H2SO4) is then added and 5 minutes later, an oxidant, potassium ferricyanide (5 mmol/L K3Fe(CN), in 10 mmol/L sodium phosphate buffer [pH 7.6]), is added. Five minutes after addition of oxidant, the end-points are read at absorbances of 700 and 660 nm. As the assay is based on an increase in absorbance over baseline, no blank without enzyme was used. The detection limit of the assay is 1.5 umol/L defined by quantification of a serial dilution of a plasma sample of tHCY diluted to 0.77 umol/L. The limit of quantification is defined as the lowest concentration measured having a CV

Here's an analysis of the provided text regarding the A/C Enzymatic Homocysteine Assay, focusing on acceptance criteria and the supporting study:

1. Table of Acceptance Criteria and Reported Device Performance

The document doesn't explicitly state formal "acceptance criteria" in a clear, quantified manner for regulatory approval. Instead, it describes performance characteristics and compares them to a predicate device. The performance is deemed acceptable because it is within ranges reported for currently-used assays including the predicate.

Here's a table summarizing the performance characteristics presented, with an interpretation of implied acceptance based on the comparison to existing assays:

Ask a specific question about this device